Growth and hormone deficiency and peak bone mass

Area of Science:

• Endocrinology
• Bone Biology
• Metabolic Disorders

Background:

• Optimal peak bone mass is crucial for skeletal health.
• The role of growth hormone (GH) in achieving peak bone mass requires further elucidation.
• Long-term effects of GH on bone are not fully understood due to the long lag time between growth cessation and peak bone mass attainment.

Purpose of the Study:

• To define the relationship between growth hormone (GH) and peak bone mass.
• To assess the importance of GH in reaching optimal peak bone mass.
• To evaluate the long-term effects of GH replacement therapy on bone in adults with GH deficiency.

Main Methods:

• Review of existing literature and studies on GH and bone health.
• Analysis of data from controlled and uncontrolled studies on long-term GH replacement therapy.
• Assessment of bone mineral density and bone mineral content changes over time.

Main Results:

• Long-term GH replacement therapy in adults with GH deficiency has no deleterious effects on bone.
• GH therapy leads to a slow, sustained increase in bone mineral density and content over time.
• Despite increased bone turnover and remodeling space, bone mass parameters improve with GH therapy.

Conclusions:

• Current evidence suggests that long-term GH replacement therapy is safe for bone health in adults with GH deficiency.
• GH plays a role in bone metabolism, contributing to gradual improvements in bone mass.
• Further long-term research is needed to definitively establish the role of GH in optimizing peak bone mass.